Showing results (201-210 of 447) with videos related to

Sort By:
Pageof 45
The Canadian Journal of Cardiology|July 13, 2006
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in CanadaChristopher S Simpson, Jeffrey S Healey, Francois Philippon, et al.
JAMA|January 13, 2006
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trialStuart J Connolly, Paul Dorian, Robin S Roberts, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 19, 2017
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) studyPaolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, et al.
The Canadian Journal of Cardiology|May 13, 2022
Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial FibrillationAlireza Oraii, Jeff S Healey, Alexander P Benz, et al.
The Canadian Journal of Cardiology|July 13, 2024
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic ApproachesJohn W Eikelboom, Qilong Yi, William F McIntyre, et al.
Heart Rhythm|February 5, 2008
Complications associated with defibrillation threshold testing: the Canadian experienceDavid Birnie, Stanley Tung, Christopher Simpson, et al.
Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Circulation|June 16, 2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trialJeff S Healey, John Eikelboom, James Douketis, et al.
Circulation|July 31, 2015
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and OutcomesWobo Bekwelem, Stuart J Connolly, Jonathan L Halperin, et al.
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Pageof 45